Triamterene

BreastfeedingPediatric
  • TRADE NAMES: Amterene; Diarrol; Diuteren; Dyazide (GSK); Dyrenium (Concordia); Dytac; Maxzide; Reviten; Suloton; Trian
  • INDICATIONS: Edema
  • CLASS: Diuretic, potassium-sparing
  • HALF-LIFE: 1–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Acemetacin, Benazepril, Captopril, Cyclosporine, Enalapril, Fosinopril, Indomethacin, Lisinopril, Metformin, Moexipril, Potassium Iodide, Potassium salts, Quinapril, Ramipril, Spironolactone, Trandolapril, Zofenopril

PREGNANCY CATEGORY: C

Dyazide and Maxzide are triamterene and hydrochlorothiazide.

Hydrochlorothiazide is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.

Our database has 14 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
ENDOCRINE/METABOLIC
RENAL
OCULAR


Page last updated 02/02/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric